Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update.
Toplak H, Ludvik B, Lechleitner M, Dieplinger H, Föger B, Paulweber B, Weber T, Watschinger B, Horn S, Wascher TC, Drexel H, Brodmann M, Pilger E, Rosenkranz A, Pohanka E, Oberbauer R, Traindl O, Roithinger FX, Metzler B, Haring HP, Kiechl S. Toplak H, et al. Among authors: lechleitner m. Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S216-28. doi: 10.1007/s00508-016-0993-x. Wien Klin Wochenschr. 2016. PMID: 27052248 Free PMC article.
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2].
Clodi M, Abrahamian H, Drexel H, Fasching P, Föger B, Francesconi C, Hoppichler F, Kaser S, Kautzky-Willer A, Lechleitner M, Ludvik B, Prager R, Fröhlich-Reiterer E, Roden M, Säly C, Schernthaner G, Sourij H, Toplak H, Wascher TC, Weitgasser R. Clodi M, et al. Among authors: lechleitner m. Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S45-53. doi: 10.1007/s00508-016-0991-z. Wien Klin Wochenschr. 2016. PMID: 27052250 German.
[Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Lechleitner M, Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Föger B, Francesconi C, Fröhlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stöckl Y, Zlamal-Fortunat S. Lechleitner M, et al. Wien Klin Wochenschr. 2019 May;131(Suppl 1):39-46. doi: 10.1007/s00508-019-1492-7. Wien Klin Wochenschr. 2019. PMID: 30980147 Free article. Review. German.
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].
Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Föger B, Francesconi C, Fröhlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Lechleitner M, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stöckl Y, Zlamal-Fortunat S. Clodi M, et al. Among authors: lechleitner m. Wien Klin Wochenschr. 2019 May;131(Suppl 1):27-38. doi: 10.1007/s00508-019-1471-z. Wien Klin Wochenschr. 2019. PMID: 30980148 Free article. Review. German.
[Insulin therapy of diabetes].
Lechleitner M, Roden M, Weitgasser R, Ludvik B, Fasching P, Hoppichler F, Kautzky-Willer A, Schernthaner G, Prager R, Wascher TC. Lechleitner M, et al. Wien Klin Wochenschr. 2012 Dec;124 Suppl 2:17-22. doi: 10.1007/s00508-012-0266-2. Wien Klin Wochenschr. 2012. PMID: 23250454 German.
[Diabetes and lipids].
Lechleitner M, Drexel H. Lechleitner M, et al. Wien Med Wochenschr. 2003;153(21-22):469-73. doi: 10.1007/s10354-003-0037-9. Wien Med Wochenschr. 2003. PMID: 14679889 Review. German.
[Antihyperglycemic Treatment Guidelines for diabetes mellitus type 2].
Clodi M, Abrahamian HE, Drexel H, Fasching P, Hoppichler F, Kautzky-Willer A, Lechleitner M, Ludvik B, Prager R, Roden M, Saely C, Schernthaner G, Schober E, Toplak H, Wascher T, Weitgasser R. Clodi M, et al. Among authors: lechleitner m. Wien Klin Wochenschr. 2012 Dec;124 Suppl 2:10-6. doi: 10.1007/s00508-012-0263-5. Wien Klin Wochenschr. 2012. PMID: 23262748 German.
Are there differences in LDL-C target value attainment in Austrian federal states? Yes!
Pichler M, Lautsch D, Adler C, Bögl K, Drexel H, Eber B, Fauer C, Föchterle J, Föger B, Gansch K, Grafinger P, Lechleitner M, Ludvik B, Maurer G, Mörz R, Paulweber B, Pfeiffer KP, Prager R, Stark G, Toplak H, Traindl O, Weitgasser R. Pichler M, et al. Among authors: lechleitner m. Wien Med Wochenschr. 2013 Dec;163(23-24):528-35. doi: 10.1007/s10354-013-0219-z. Epub 2013 Aug 27. Wien Med Wochenschr. 2013. PMID: 23979353 Free PMC article. Clinical Trial.
[Insulin therapy of diabetes].
Lechleitner M, Roden M, Weitgasser R, Ludvik B, Fasching P, Hoppichler F, Kautzky-Willer A, Schernthaner G, Prager R, Wascher TC. Lechleitner M, et al. Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S54-61. doi: 10.1007/s00508-015-0925-1. Wien Klin Wochenschr. 2016. PMID: 27052221 Review. German.
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2019)].
Lechleitner M, Kaser S, Hoppichler F, Roden M, Weitgasser R, Ludvik B, Fasching P, Winhofer-Stöckl Y, Kautzky-Willer A, Schernthaner G, Prager R, Wascher TC, Clodi M. Lechleitner M, et al. Wien Klin Wochenschr. 2019 May;131(Suppl 1):77-84. doi: 10.1007/s00508-019-1493-6. Wien Klin Wochenschr. 2019. PMID: 30980145 Review. German.
223 results